Literature DB >> 31595007

Dissemination of carbapenemase-producing Enterobacteriaceae harbouring blaNDM or blaIMI in local market foods of Yangon, Myanmar.

Yo Sugawara1, Hideharu Hagiya2, Yukihiro Akeda3,4, Mya Mya Aye5, Hpoo Pwint Myo Win5, Noriko Sakamoto1, Rathina Kumar Shanmugakani2, Dan Takeuchi1, Isao Nishi6, Akiko Ueda6, Moh Moh Htun5, Kazunori Tomono2, Shigeyuki Hamada1.   

Abstract

The spread of carbapenemase-producing Enterobacteriaceae (CPE) poses a serious threat to clinical practice and public health. These bacteria are present both in clinical settings and non-clinical environments. The presence of CPE in food stuffs has been reported, but sporadically so. Here, we screened for CPE in meat, seafood, and vegetable samples from local markets of Yangon, Myanmar. We obtained 27 CPE isolates from 93 food samples and identified 13 as Escherichia coli, six as Klebsiella pneumoniae, seven as Enterobacter cloacae complex, and one as Serratia marcescens. All except the E. cloacae complex harboured the carbapenemase genes blaNDM-1 or blaNDM-5, while all Enterobacter isolates carried the carbapenemase gene blaIMI-1. The blaIMI-1 gene was located in putative mobile elements EcloIMEX-2, -3, or -8. Using multi-locus sequence typing, E. coli, K. pneumoniae, and E. cloacae complex isolates were classified into 10, six, and five different sequence types, respectively. Our results demonstrate that diverse organisms with various carbapenemase genes are widespread in the market foods in Yangon, highlighting the need for promoting proper food hygiene and effective measures to prevent further dissemination.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31595007      PMCID: PMC6783431          DOI: 10.1038/s41598-019-51002-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Carbapenem-resistant Enterobacteriaceae have become a global public-health concern because these bacteria cause high mortality and are multidrug-resistant[1]. This resistance is mainly due to the production of carbapenemases, which hydrolyse carbapenem antibiotics. Carbapenemase genes such as blaNDM are often in transmissible plasmids and thus spread readily among Enterobacteriaceae species[2]. Currently, carbapenemase-producing Enterobacteriaceae (CPE) are found in both clinical and non-clinical settings, including sewage systems[3,4]. Alarmingly, CPE have been isolated from imported food stuffs (vegetables and seafood) originating in southeast Asian countries[5,6]. Despite the potential danger, thorough food surveillance is not performed on retail foods in CPE-endemic regions, with a few exceptions in China[7,8]. Previously, we identified genetically diverse Enterobacteriaceae isolates with blaNDM-harbouring plasmids in a hospital of Yangon, Myanmar’s largest city[9,10]. We then found closely related strains in sewage water outside the hospital[10], implying that CPE in clinical settings could reach the external environment. These findings prompted us to investigate the extent of CPE dissemination in local communities. Here, we focused on the spread of CPE in local markets.

Results

Diverse E. coli and K. pneumoniae isolates harbouring blaNDM from market foods

Of the 93 food samples from eight markets, we identified 20 CPE-positive samples (21.5%). Within each food category (meat, seafood, and vegetables), the percentage of CPE-positive samples was 25.0% (8/32), 10.3% (3/29), and 28.1% (9/32), respectively (Table 1). We obtained 27 CPE isolates from the 20 samples, with 16 (59.3%) derived from vegetables. Water spinach exhibited the highest CPE-positive rate (4/8, 50%) and yielded eight CPE isolates. Of the 27 CPE isolates, 20 carried blaNDM, including 13 Escherichia coli, six Klebsiella pneumoniae, and one Serratia marcescens. All but one E. coli, along with four of six K. pneumoniae, possessed blaNDM-5; the remaining carried blaNDM-1 (Fig. 1). Every blaNDM-carrying isolate was resistant to imipenem. Those harbouring blaNDM-5 were also resistant to meropenem, but blaNDM-1 did not confer resistance to this antibiotic. All isolates were resistant to extended-spectrum cephalosporin and oxacephem antibiotics, such as ceftazidime and moxalactam, and the minimum inhibitory concentration for these antibiotics was >64 µg/mL and ≥128 µg/mL, respectively. Additionally, 80% (16/20), 55% (11/20), and 70% (14/20) of isolates were resistant to gentamycin, amikacin, and levofloxacin, respectively.
Table 1

Isolation of CPE from food samples in the markets of Yangon, Myanmar. ECC, E. cloacae complex; Sm, S. marcescens.

SourceNo. of samplesNo. of CPE-positive samples (%)No. of IsolatesSpecies (no.)
Beef82 (25.0)2E. coli
Chicken83 (37.5)3E. coli, K. pneumoniae, ECC
Mutton81 (12.5)1ECC
Pork82 (25.0)2E. coli
Clam51 (20.0)1E. coli
Fish81 (12.5)1ECC
Squid80 (0)0
Prawn81 (12.5)1K. pneumoniae
Chinese cabbage82 (25.0)4E. coli, K. pneumoniae, ECC, Sm
Lettuce81 (12.5)1E. coli
Roselle82 (25.0)3E. coli, K. pneumoniae, ECC
Water spinach84 (50.0)8E. coli (4), K. pneumoniae (2), ECC (2)
Total9320 (21.5)27
Figure 1

Phenotypic and genetic characteristics of CPE isolates harbouring blaNDM. Ec, Escherichia coli; Kp, Klebsiella pneumoniae; Sm, Serratia marcescens. Food samples were obtained from southern (S), western (W), eastern (E), and northern (N) districts of Yangon. Grey cells indicate isolates resistant to the indicated antimicrobials. MIC, minimum inhibitory concentration. Numbers and alphabets in columns denote variant types. For GyrA and ParC, presence of amino acid substitution in the indicated residues are marked in dark yellow. Genes with nucleotide substitution(s) compared with sequences in the ResFinder database are marked with asterisks. Southern blots identified blaNDM-5 gene on chromosomes. NA, not applicable.

Isolation of CPE from food samples in the markets of Yangon, Myanmar. ECC, E. cloacae complex; Sm, S. marcescens. Phenotypic and genetic characteristics of CPE isolates harbouring blaNDM. Ec, Escherichia coli; Kp, Klebsiella pneumoniae; Sm, Serratia marcescens. Food samples were obtained from southern (S), western (W), eastern (E), and northern (N) districts of Yangon. Grey cells indicate isolates resistant to the indicated antimicrobials. MIC, minimum inhibitory concentration. Numbers and alphabets in columns denote variant types. For GyrA and ParC, presence of amino acid substitution in the indicated residues are marked in dark yellow. Genes with nucleotide substitution(s) compared with sequences in the ResFinder database are marked with asterisks. Southern blots identified blaNDM-5 gene on chromosomes. NA, not applicable. Resistant isolates possessed multiple genes encoding aminoglycoside modification enzymes, chromosomal point mutation in quinolone-resistance-determining regions of gyrA and parC, as well as plasmid-mediated quinolone-resistance determinants. Notably, we found the 16S rRNA methylase gene rmtB in nine isolates resistant to gentamycin and amikacin. In contrast, all isolates except one were susceptible to fosfomycin and colistin. The only isolate resistant to the latter antibiotic was classified as Serratia, known to be intrinsically colistin-resistant[11]. Multilocus sequence typing (MLST) classified 13 E. coli isolates into 10 sequence types (STs) and six K. pneumoniae isolates each into a different ST (Fig. 1). Further evidence of isolate diversity includes blaNDM presence in differently sized plasmids or chromosomes (Fig. 1).

Carbapenemase-producing E. cloacae complex possesses blaIMI-1

Using the carbapenem-inactivation method (CIM), we identified seven carbapenemase-positive isolates of Enterobacter cloacae complex that are negative for blaNDM, blaKPC, blaIMP, or blaOXA-48 according to a PCR-dipstick test. Instead, whole genome sequencing revealed that they all possessed blaIMI-1, a chromosomally encoded Ambler class A serine β-lactamase gene. In accordance with an earlier report[12], blaIMI-1 presence conferred high resistance to imipenem and meropenem, but not to extended-spectrum cephalosporin and oxacephem antibiotics, such as ceftazidime and moxalactam (Fig. 2). These bacteria were also susceptible to gentamycin, minocycline, and levofloxacin. Five isolates out of seven were resistant to fosfomycin, and three were resistant to colistin, a last-resort antibiotic for treating CPE infections.
Figure 2

Phenotypic and genetic characteristics of E. cloacae complex isolates harbouring blaIMI-1. Phylogenetic groups were classified according to Chavda et al.[13]. Isolates resistant to the indicated antimicrobials are represented as grey shaded cells. MIC, minimum inhibitory concentration. *Genes with nucleotide substitutions compared with sequences in ResFinder.

Phenotypic and genetic characteristics of E. cloacae complex isolates harbouring blaIMI-1. Phylogenetic groups were classified according to Chavda et al.[13]. Isolates resistant to the indicated antimicrobials are represented as grey shaded cells. MIC, minimum inhibitory concentration. *Genes with nucleotide substitutions compared with sequences in ResFinder. These six isolates were newly assigned to five STs representing previously undetected populations. We used whole-genome sequencing data of these isolates and those from the GenBank database to generate a core-genome single-nucleotide-polymorphism-based phylogenetic tree of the E. cloacae complex (Fig. 3). This tree grouped the newly assigned isolates into three clusters (G, M, and N)[13]. Each isolate carried blaIMI-1 between setB and yeiP; the gene was encoded on an integrative mobile element designated as EcloIMEX[14]. We identified three mobile elements, EcloIMEX-2 (GenBank accession number KR057494.1), -3 (KU870977.1), and -8 (MG547711.1). Of these, EcloIMEX-3 was found in phylogenetically different isolates, F038 and F054V.
Figure 3

Phylogenetic analysis based on core-genome SNPs separates market-food-derived IMI-1-producing isolates into groups G, M, and N of the E. cloacae complex. A phylogenetic tree was constructed using the genome of E. cloacae ATCC13047 (GenBank accession number NC_014121.1) as a reference. Genomic sequences of other E. cloacae complex strains were retrieved from NCBI and included in the analysis. The food isolates acquired in this study are in bold; strains belonging to groups G, M, and N are marked in grey.

Phylogenetic analysis based on core-genome SNPs separates market-food-derived IMI-1-producing isolates into groups G, M, and N of the E. cloacae complex. A phylogenetic tree was constructed using the genome of E. cloacae ATCC13047 (GenBank accession number NC_014121.1) as a reference. Genomic sequences of other E. cloacae complex strains were retrieved from NCBI and included in the analysis. The food isolates acquired in this study are in bold; strains belonging to groups G, M, and N are marked in grey.

Discussion

This study found diverse CPE in local market foods with higher isolation rates than previously reported (2.4%)[8]. Vegetables were the most contaminated, exhibiting the highest CPE-positive rate (28.1%) and containing approximately 60% of isolates identified. Following vegetables, meat samples had high isolation rates (25.0%). Carbapenem-resistant E. coli and K. pneumoniae isolates exhibited multidrug resistance because they harboured blaNDM-1 or blaNDM-5, along with other antimicrobial-resistance determinants. Worryingly, most isolates possessed blaNDM-5, which confers higher resistance against carbapenems than blaNDM-1[15]. Furthermore, we found evidence that E. coli isolates harbouring blaNDM have clinical links; five of the 10 STs identified had been previously detected in a tertiary-care hospital of Yangon[10]. In contrast, NDM-producing K. pneumoniae isolates belonged to STs that have not been detected thus far from Yangon clinical specimens, although four (ST15, 16, 39, 395) have been found in clinical isolates from other countries[16,17]. Notably, we identified isolate F069 in chicken and showed that it was resistant to all tested antibiotics except colistin. This strain belongs to ST395, a constituent of worldwide epidemic clonal group 258[18]. Isolation of IMI-type carbapenemase is relatively rare. Here, we provided valuable empirical evidence of diverse IMI-producing E. cloacae complexes existing outside hospitals, confirming previous long-term clinical observations that suggested that these bacteria are present in local communities[14,19]. Moreover, we confirmed the presence of IMI-type carbapenemase in Myanmar, suspected ever since blaIMI-2 was detected in a Dutch individual travelling to the country[20]. We linked blaIMI-1 to a putative mobile element EcloIMEX in all isolates containing the gene. Among the three EcloIMEX detected, EcloIMEX-3 was found in genetically different group N (F038) and G (F054V) isolates, suggesting independent acquisition of the element. Thus, EcloIMEX is probably responsible for mobilizing blaIMI-type genes to E. cloacae complex[14,19]. We isolated a blaIMI-1-harbouring E. coloacae complex from fish and water spinach, which is usually cultivated in water-rich regions, corroborating previous reports that associated these bacteria with aquatic environments[6,21,22]. Of note, we isolated two water spinach isolates of the same ST and EcloIMEX type from different districts, suggesting the existence of a shared reservoir of blaIMI-1 dissemination. Other sources are also likely, given the presence of blaIMI-1-harbouring isolates in other vegetables, as well as chicken and mutton, across all four surveyed districts. Overall, our results demonstrate widespread dissemination of blaIMI-1-harbouring E. coloacae complex in Yangon. These organisms are susceptible to several common antibiotics, meaning that multiple treatment options are available in the event of infection such as reported previously[23,24]. However, they may sporadically become more resistant to drugs through acquiring multidrug-resistance plasmids in local communities. We therefore strongly recommend vigorous countermeasures to prevent pathogen spread through daily consumption of food stuffs in regions heavily contaminated by CPE and other multidrug-resistant microbes. In conclusion, this study provided evidence that local market foods in Yangon, Myanmar frequently harboured diverse CPE isolates, some with highly drug-resistant phenotypes. We note two important limitations of our study: the small sample size and the possible existence of multiple sources for CPE spread. These factors prevented us from tracking exact CPE dissemination profiles in market food samples. Thus, further study is necessary to fully understand the extent of CPE dissemination in this region and to identify the major source(s) of their spread. Such knowledge will enable the development of effective countermeasures against contamination of food with CPE. Nevertheless, our research highlights the immediate need to take corrective action against the current situation of CPE contamination in food.

Methods

Isolation of carbapenemase-producing organisms from market food

Food sampling and bacterial isolation were conducted as previously described[25]. From November to December 2017, chicken, pork, beef, fish, clam, and assorted vegetables were collected from eight street stalls in Yangon. Samples were placed in an ice box and transported to the laboratory at the Department of Medical Research, Yangon, where they were either examined immediately or stored at 4 °C until further analysis. For sample processing, 25 g of flesh was mixed with 225 mL buffered peptone water in a stomacher bag and incubated at 35 °C for 18 ± 2 h. Subsequently, a loopful of enrichment culture was streaked onto CHROMagar ECC (CHROMagar, Paris, France), supplemented with 0.25 μg/mL meropenem and 70 μg/mL ZnSO4[26], then cultured at 35 °C for 24 ± 2 h.

Bacterial identification, antimicrobial-susceptibility tests, and PCR for carbapenemase genes

Bacteria were identified with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI Biotyper; Bruker Daltonics, Germany). Antimicrobial susceptibility was measured using a MicroScan WalkAway 96 Plus (Beckman Coulter, Brea, CA, USA) and dry plate (Eiken Chemical, Tokyo, Japan), then classified based on the Clinical and Laboratory Standards Institute Guidelines (M100-S24). For colistin, resistance was defined according to the European Committee on Antimicrobial Susceptibility Testing criteria. Carbapenem-resistant Enterobacteriaceae isolates were screened for carbapenemase production using CIM[27]. In addition, PCR-dipstick chromatography was performed to detect four major carbapenemase genes (blaNDM, blaKPC, blaIMP, and blaOXA-48)[28].

Whole-genome sequencing and plasmid analysis

Bacterial isolates were cultured overnight in brain-heart infusion broth (BD Bacto, Franklin Lakes, NJ, USA) containing 0.25 μg/mL meropenem. Genomic DNA was then prepared using a PowerSoil DNA isolation kit (Qiagen, Valencia, CA, USA). Library preparation was performed as described previously[9] or using KAPA Hyper Plus Kits (KAPA Biosystems, Woburn, MA, USA). Paired-end sequencing with 250 bp reads was performed in MiSeq (Illumina, San Diego, CA, USA). Reads were then de novo-assembled using CLC Genomics Workbench 11.0.1 (CLC Bio, Aarhus, Denmark) for subsequent analyses. Multilocus sequence typing for E. coli and K. pneumoniae were performed using EnteroBase (http://enterobase.warwick.ac.uk/) and the Institute Pasteur’s MLST database (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html), respectively. Existing methods[29] were followed for MLST of the E. cloacae complex. Resistance-gene identification was performed in ResFinder 2.1[30]. Evolutionary relatedness of isolates was assessed using CSI Phylogeny 1.4[31], and iTOL was used to construct the phylogenetic tree[32]. To classify EcloIMEX, local BLAST searches were performed on sequences around blaIMI-1, which contain setB and yeiP genes. To determine the blaNDM-harbouring plasmid size, pulsed-field electrophoresis (PFGE) plugs prepared from isolates were treated with S1 nuclease (Takara Bio, Shiga, Japan) and subjected to PFGE in the CHEF Mapper XA system (Bio-Rad, Hercules, CA, USA). Separated DNA was then transferred to a nylon membrane and probed with a digoxigenin-labelled (Roche Diagnostics, Basel, Switzerland), blaNDM-specific DNA probe for Southern hybridization.
  32 in total

1.  PCR-Dipstick Chromatography for Differential Detection of Carbapenemase Genes Directly in Stool Specimens.

Authors:  Rathina Kumar Shanmugakani; Yukihiro Akeda; Norihisa Yamamoto; Noriko Sakamoto; Hideharu Hagiya; Hisao Yoshida; Dan Takeuchi; Yo Sugawara; Takuya Kodera; Mitsuo Kawase; Warawut Laolerd; Narong Chaihongsa; Pitak Santanirand; Yoshikazu Ishii; Shigeyuki Hamada; Kazunori Tomono
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Authors:  B A Rasmussen; K Bush; D Keeney; Y Yang; R Hare; C O'Gara; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Putative Integrative Mobile Elements That Exploit the Xer Recombination Machinery Carrying blaIMI-Type Carbapenemase Genes in Enterobacter cloacae Complex Isolates in Singapore.

Authors:  Tse H Koh; Nurdyana Binte Abdul Rahman; Jeanette W P Teo; My-Van La; Balamurugan Periaswamy; Swaine L Chen
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Characteristics of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Retail Meats and Shrimp at a Local Market in Vietnam.

Authors:  Quoc Phong Le; Shuhei Ueda; Thi Ngoc Hue Nguyen; Thi Van Khanh Dao; Thi Ai Van Hoang; Thi Thuy Nga Tran; Itaru Hirai; Tatsuya Nakayama; Ryuji Kawahara; Thai Hung Do; Quang Mai Vien; Yoshimasa Yamamoto
Journal:  Foodborne Pathog Dis       Date:  2015-06-25       Impact factor: 3.171

5.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

Authors:  Timothy R Walsh; Janis Weeks; David M Livermore; Mark A Toleman
Journal:  Lancet Infect Dis       Date:  2011-04-07       Impact factor: 25.071

6.  Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

Authors:  A C Gales; R N Jones; H S Sader
Journal:  Clin Microbiol Infect       Date:  2006-04       Impact factor: 8.067

Review 7.  Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.

Authors:  Elizabeth Temkin; Amos Adler; Anat Lerner; Yehuda Carmeli
Journal:  Ann N Y Acad Sci       Date:  2014-09       Impact factor: 5.691

8.  The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.

Authors:  Kim van der Zwaluw; Angela de Haan; Gerlinde N Pluister; Hester J Bootsma; Albert J de Neeling; Leo M Schouls
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae.

Authors:  Tohru Miyoshi-Akiyama; Kayoko Hayakawa; Norio Ohmagari; Masahiro Shimojima; Teruo Kirikae
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.

Authors:  Kalyan D Chavda; Liang Chen; Derrick E Fouts; Granger Sutton; Lauren Brinkac; Stephen G Jenkins; Robert A Bonomo; Mark D Adams; Barry N Kreiswirth
Journal:  MBio       Date:  2016-12-13       Impact factor: 7.867

View more
  8 in total

1.  Carbapenemase-Producing Gram-Negative Bacteria from American Crows in the United States.

Authors:  Iva Kutilova; Adam Valcek; Costas C Papagiannitsis; Darina Cejkova; Martina Masarikova; Veronika Paskova; Lenka Davidova-Gerzova; Petra Videnska; Jaroslav Hrabak; Ivan Literak; Monika Dolejska
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital.

Authors:  Vered Schechner; Katya Levytskyi; Ohad Shalom; Alexander Yalek; Amos Adler
Journal:  Antimicrob Resist Infect Control       Date:  2021-11-29       Impact factor: 4.887

3.  Dominant Carbapenemase-Encoding Plasmids in Clinical Enterobacterales Isolates and Hypervirulent Klebsiella pneumoniae, Singapore.

Authors:  Melvin Yong; Yahua Chen; Guodong Oo; Kai Chirng Chang; Wilson H W Chu; Jeanette Teo; Indumathi Venkatachalam; Natascha May Thevasagayam; Prakki S Rama Sridatta; Vanessa Koh; Andrés E Marcoleta; Hanrong Chen; Niranjan Nagarajan; Marimuthu Kalisvar; Oon Tek Ng; Yunn-Hwen Gan
Journal:  Emerg Infect Dis       Date:  2022-08       Impact factor: 16.126

4.  Spread of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates Producing NDM-Type Metallo-β-Lactamase in Myanmar.

Authors:  Satomi Takei; Yu Jie Lu; Mari Tohya; Shin Watanabe; Shigeki Misawa; Yoko Tabe; Takashi Miida; San Mya; Htay Htay Tin; Tatsuya Tada; Teruo Kirikae
Journal:  Microbiol Spectr       Date:  2022-06-28

5.  Prevalence and Characterization of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacterales from Tunisian Seafood.

Authors:  Mehdi Sola; Yosra Mani; Estelle Saras; Antoine Drapeau; Raoudha Grami; Mahjoub Aouni; Jean-Yves Madec; Marisa Haenni; Wejdene Mansour
Journal:  Microorganisms       Date:  2022-07-06

6.  Genomic Analysis of Carbapenemase-Producing Extensively Drug-Resistant Klebsiella pneumoniae Isolates Reveals the Horizontal Spread of p18-43_01 Plasmid Encoding blaNDM-1 in South Africa.

Authors:  Yogandree Ramsamy; Koleka P Mlisana; Mushal Allam; Daniel G Amoako; Akebe L K Abia; Arshad Ismail; Ravesh Singh; Theroshnie Kisten; Khine Swe Han; David J Jackson Muckart; Timothy Hardcastle; Moosa Suleman; Sabiha Y Essack
Journal:  Microorganisms       Date:  2020-01-17

7.  Antimicrobials use and resistance on integrated poultry-fish farming systems in the Ayeyarwady Delta of Myanmar.

Authors:  Justine S Gibson; Honey Wai; Shwe Sin May Lwin Oo; Ei Moh Moh Hmwe; Soe Soe Wai; Lat Lat Htun; Hwee Ping Lim; Zin Min Latt; Joerg Henning
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

8.  Detection of pathological mechano-acoustic signatures using precision accelerometer contact microphones in patients with pulmonary disorders.

Authors:  Pranav Gupta; Haoran Wen; Lorenzo Di Francesco; Farrokh Ayazi
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.